Helen of Troy Limited

$24.34 ▼ -2.76%
2026-06-06 08:26:02

Explore Helen of Troy Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$574.35 M
Current Price
$24.34
52W High / Low
$33.73 / $13.85
Stock P/E
Book Value
$73.17
Dividend Yield
ROCE
7.84%
ROE
-94.52%
Face Value
EPS
$-39.15
Exp Qtr EPS
Sector
Consumer Defensive

HELE — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.
  • Valuation is not stretched on P/E basis.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. The Procter & Gamble Company $146.54 20.59 $342.1 B 3.09% 22.93% 31.23% $167.25 / $137.62 $22.21
2. Colgate-Palmolive Company $88.58 33.78 $70.5 B 2.49% 44.67% 475.13% $99.33 / $74.55 $0.07
3. Kenvue Inc. $17.71 20.96 $34 B 4.92% 12.85% 15.18% $22.87 / $14.02 $5.62
4. Kimberly-Clark Corporation $99.04 15.43 $32.7 B 5.42% 23.57% 143.64% $137.46 / $92.42 $4.53
5. The Estée Lauder Companies Inc. $83.49 $30.29 B 1.69% 7.89% -6.29% $121.64 / $66.22 $10.74
6. Church & Dwight Co., Inc. $96.74 31.03 $22.75 B 1.31% 14.53% 17.45% $106.04 / $81.33 $16.92
7. The Clorox Company $94.14 14.63 $11.06 B 5.53% 32.32% 453.68% $132.03 / $84.7 $2.62

Quarterly Results

Figures shown in M / B

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales512.83 M431.78 M371.65 M485.89 M530.71 M
Operating Profit57.54 M13.68 M7.35 M61.41 M78.64 M
Net Profit-84.06 M-308.64 M-450.72 M50.92 M49.62 M
EPS in Rs-3.64-13.38-19.542.212.150.74

Profit & Loss

Figures shown in M / B

2025202420232022
Sales1.91 B2.01 B2.07 B2.22 B
Operating Profit209.03 M279.3 M239.15 M272.93 M
Net Profit123.75 M168.59 M143.27 M223.76 M
EPS in Rs5.367.316.219.7

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets3.13 B2.84 B2.91 B2.82 B
Total Liabilities1.45 B1.2 B1.42 B1.5 B
Equity1.68 B1.64 B1.49 B1.33 B
Current Assets931.71 M843.92 M892.04 M1.08 B
Current Liabilities466.26 M450.81 M412.16 M602.69 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF113.21 M306.07 M208.24 M140.82 M
Investing CF-263.09 M5.45 M-319.33 M-438.91 M
Financing CF150.25 M-322.09 M106.78 M286.35 M
Free CF83.14 M269.42 M33.38 M62.78 M
Capex-30.07 M-36.64 M-174.86 M-78.04 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2025202420232022
Revenue Growth %-4.86%-3.26%-6.78%
Earnings Growth %-26.6%17.67%-35.97%
Profit Margin %6.49%8.41%6.91%10.06%
Operating Margin %10.96%13.93%11.54%12.28%
Gross Margin %47.93%47.31%43.39%42.87%
EBITDA Margin %10.41%15.64%12.39%13.88%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
iShares Trust-iShares Russell 2000 ETF Mutual Fund 0.56 M $8.2 M 0.02% 2026-01-31
NORTHERN LIGHTS FUND TRUST II-Invenomic Fund Mutual Fund 0.51 M $7.43 M 0.02% 2026-01-31
Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund Mutual Fund 0.49 M $7.23 M 0.02% 2026-01-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund Mutual Fund 0.22 M $3.23 M 0.01% 2026-01-31
Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund Mutual Fund 0.21 M $3.02 M 0.01% 2026-01-31
Blackrock Inc. Institutional 1.76 M $25.72 M 0.08% 2025-12-31
Vanguard Group Inc Institutional 1.53 M $22.29 M 0.07% 2025-12-31
Millennium Management Llc Institutional 1.05 M $15.32 M 0.05% 2025-12-31
Pzena Investment Management LLC Institutional 0.95 M $13.83 M 0.04% 2025-12-31
Charles Schwab Investment Management, Inc. Institutional 0.88 M $12.87 M 0.04% 2025-12-31
Ameriprise Financial, Inc. Institutional 0.78 M $11.46 M 0.03% 2025-12-31
Wellington Management Group, LLP Institutional 0.76 M $11.05 M 0.03% 2025-12-31
Shaw D.E. & Co., Inc. Institutional 0.75 M $10.93 M 0.03% 2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund Mutual Fund 0.72 M $10.47 M 0.03% 2025-12-31
Dimensional Fund Advisors LP Institutional 0.7 M $10.23 M 0.03% 2025-12-31

Frequently Asked Questions — Helen of Troy Limited

Will Helen of Troy Limited stock hit $29 in 2026?

Helen of Troy Limited (HELE) is currently trading at $24.34, with a 52-week range of $13.85 to $33.73. Reaching the $29 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $24.67 for Helen of Troy Limited, with a Hold rating, and the most bullish analysts see the stock reaching as high as $40.0. Whether Helen of Troy Limited can reach $29 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Consumer Defensive space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, HELE has delivered a -35.3% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the HELE Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Helen of Troy Limited stock worth buying at $24.34?

Whether Helen of Troy Limited (HELE) is worth buying at $24.34 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Valuation data is currently limited — check the full ratios section on StockSifting for the latest P/E, P/B, and EV/EBITDA figures.

Profitability & efficiency: Helen of Troy Limited has a Return on Capital Employed (ROCE) of 7.8%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at -94.5%.

Financial health: The Debt-to-Equity ratio of 111.11 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for HELE is currently Hold, with a mean price target of $24.67 based on 3 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Helen of Troy Limited (HELE) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $24.67 for Helen of Troy Limited (HELE), aggregated from 3 analyst ratings. The overall analyst recommendation is Hold.

The price target range spans from $16.0 on the bearish end to $40.0 on the most optimistic projection, with a median target of $18.0. This wide range reflects differing views on Helen of Troy Limited's growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the HELE analysis page on StockSifting.

What will Helen of Troy Limited stock be worth in 2029?

Projecting Helen of Troy Limited (HELE)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

Based on HELE's historical 5-year Compound Annual Growth Rate (CAGR) of -35.3%, if that rate of growth were to continue, the stock could reach approximately $7 by 2029 — up from its current price of $24.34. This projection assumes the historical CAGR holds, which depends on Helen of Troy Limited sustaining its revenue growth, maintaining profit margins, and the market continuing to reward it at a similar valuation multiple.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the HELE Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.